Search results for rs2395185
Variant information
Variant: | rs2395185 |
Pos (hg19): | chr6:32433167 |
Effect allele (A1): | G |
Other allele (A2): | T |
A1 freq (EUR) | 0.6789 |
Function | intron |
Gene | HLA-DRB9 |
Association results
Variant information
Variant: | rs2395185 |
Pos (hg19): | chr6:32433167 |
Effect allele (A1): | G |
Other allele (A2): | T |
A1 freq (EUR) | 0.6789 |
Function | intron |
Gene | HLA-DRB9 |
Top 1000 associations
SNP | rsID | Pos (hg19) | r2 | A1 | A2 | Trait | Type | PMID | Beta | P | N | Unit |
---|---|---|---|---|---|---|---|---|---|---|---|---|
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Rheumatoid arthritis | Diseases and traits | 24390342 | -0.7467 | 1.00e-250 | 58284 | log OR |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Rheumatoid arthritis | Diseases and traits | 24390342 | -0.6981 | 1.00e-250 | 80799 | log OR |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Rheumatoid arthritis | Diseases and traits | 20453842 | NA | 1.43e-235 | 25708 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Rheumatoid arthritis | Diseases and traits | 20453842 | -0.802 | 1.43e-235 | 25692 | log OR |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Rheumatoid arthritis | Diseases and traits | 19503088 | NA | 4.42e-125 | 6922 | - |
rs2395185 | rs9268853 | chr6:32429643 | 1 | T | C | Arthritis rheumatoid | Diseases and traits | 21653640 | NA | 5.00e-109 | - | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Rheumatoid arthritis | Diseases and traits | 24390342 | -0.5822 | 1.10e-107 | 22515 | log OR |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Rheumatoid arthritis | Diseases and traits | 17804836 | NA | 1.15e-83 | 3324 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Primary sclerosing cholangitis | Diseases and traits | 27992413 | 0.6554 | 4.66e-79 | 14890 | log OR |
rs2395185 | rs9268853 | chr6:32429643 | 1 | T | C | Rheumatoid arthritis combined control dataset | Diseases and traits | 17554300 | NA | 1.48e-75 | 4806 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Rheumatoid arthritis ACPA positive | Diseases and traits | 21156761 | NA | 2.61e-66 | 2226 | - |
rs2395185 | rs9268853 | chr6:32429643 | 1 | T | C | Ulcerative colitis | Diseases and traits | 21297633 | 0.3365 | 1.00e-55 | - | log OR |
rs2395185 | rs9268853 | chr6:32429643 | 1 | T | C | Colitis ulcerative | Diseases and traits | 21297633 | NA | 1.00e-55 | - | - |
rs2395185 | rs9268853 | chr6:32429643 | 1 | T | C | Ulcerative colitis | Diseases and traits | 21297633 | NA | 1.35e-55 | 26405 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Ulcerative colitis | Diseases and traits | 23128233 | NA | 1.21e-54 | 20672 | log OR |
rs2395185 | rs9268905 | chr6:32432077 | 1 | G | C | Giant cell arteritis | Diseases and traits | 28041642 | NA | 2.00e-54 | - | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | White blood cell count | Diseases and traits | 27863252 | -0.0571 | 3.98e-49 | 173480 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Self-reported asthma | Diseases and traits | UKBB | -0.01161 | 2.54e-46 | 337159 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Asthma | Diseases and traits | UKBB | -0.01148 | 1.63e-45 | 336782 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Self-reported psoriasis | Diseases and traits | UKBB | -0.00382 | 2.70e-45 | 337159 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Treatment with methotrexate | Diseases and traits | UKBB | -0.002494 | 6.57e-42 | 337159 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Granulocyte count | Diseases and traits | 27863252 | -0.05178 | 1.26e-40 | 173480 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Sum neutrophil eosinophil counts | Diseases and traits | 27863252 | -0.05166 | 1.40e-40 | 173480 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Myeloid white cell count | Diseases and traits | 27863252 | -0.05117 | 1.67e-39 | 173480 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Self-reported rheumatoid arthritis | Diseases and traits | UKBB | -0.003422 | 5.09e-38 | 337159 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Self-reported hyperthyroidism or thyrotoxicosis | Diseases and traits | UKBB | 0.002825 | 7.36e-38 | 337159 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Ulcerative colitis | Diseases and traits | 26192919 | 0.3485 | 2.18e-37 | 27432 | log OR |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Neutrophil count | Diseases and traits | 27863252 | -0.0485 | 5.10e-36 | 173480 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Sum basophil neutrophil counts | Diseases and traits | 27863252 | -0.04844 | 8.27e-36 | 173480 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Total classical Hodgkin lymphoma | Diseases and traits | 22286212 | NA | 3.80e-31 | 7617 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Hodgkins lymphoma | Diseases and traits | 22286212 | NA | 4.00e-31 | - | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Hodgkin disease | Diseases and traits | 22286212 | NA | 4.00e-31 | - | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Self-reported malabsorption or coeliac disease | Diseases and traits | UKBB | 0.001799 | 2.79e-27 | 337159 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Self-reported multiple sclerosis | Diseases and traits | UKBB | 0.001645 | 5.73e-27 | 337159 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Sum eosinophil basophil counts | Diseases and traits | 27863252 | -0.04109 | 1.78e-26 | 173480 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Wheeze or whistling in the chest in last year | Diseases and traits | UKBB | -0.01094 | 5.02e-26 | 331257 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Eosinophil count | Diseases and traits | 27863252 | -0.04013 | 2.22e-25 | 173480 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Treatment with folic acid product | Diseases and traits | UKBB | -0.002289 | 2.02e-23 | 337159 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Other rheumatoid arthritis | Diseases and traits | UKBB | -0.001339 | 5.00e-23 | 337199 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Ulcerative colitis | Diseases and traits | 20228799 | NA | 8.75e-23 | 9484 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Treatment with insulin product | Diseases and traits | UKBB | -0.002449 | 1.52e-22 | 337159 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Ulcerative colitis | Diseases and traits | 19915573 | 0.6523 | 5.00e-22 | - | log OR |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Colitis ulcerative | Diseases and traits | 19915573 | NA | 5.00e-22 | - | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Ulcerative colitis | Diseases and traits | 19915573 | NA | 5.32e-22 | 1310 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Lymphocyte count | Diseases and traits | 27863252 | -0.03668 | 3.98e-21 | 173480 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Ulcerative colitis | Diseases and traits | 19915574 | NA | 7.40e-19 | 8571 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Asthma | Diseases and traits | 29273806 | -0.1116 | 1.15e-18 | 142486 | log OR |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Inflammatory bowel disease | Diseases and traits | 26192919 | 0.1832 | 3.93e-18 | 34652 | log OR |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Treatment with ventolin 100micrograms inhaler | Diseases and traits | UKBB | -0.003645 | 9.37e-18 | 337159 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Type 1 diabetes | Diseases and traits | 17632545 | NA | 1.00e-16 | 3105 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Ulcerative colitis | Diseases and traits | 19122664 | NA | 1.00e-16 | 3525 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Ulcerative colitis | Diseases and traits | 19122664 | NA | 1.00e-16 | - | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Colitis ulcerative | Diseases and traits | 19122664 | NA | 1.00e-16 | - | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Asthma | Diseases and traits | 29273806 | -0.1119 | 1.56e-16 | 127669 | log OR |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Number of treatments or medications taken | Diseases and traits | UKBB | -0.01646 | 4.99e-16 | 337159 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Doctor diagnosed asthma | Diseases and traits | UKBB | -0.01377 | 5.09e-16 | 83529 | risk diff |
rs2395185 | rs28895235 | chr6:32437160 | 1 | T | A | Body mass index | Diseases and traits | 28892062 | -0.031 | 8.00e-16 | - | kg/m |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Diabetes diagnosed by doctor | Diseases and traits | UKBB | -0.00429 | 2.65e-15 | 336473 | risk diff |
rs2395185 | rs9268923 | chr6:32432835 | 1 | C | T | Ulcerative colitis | Diseases and traits | 20228798 | NA | 4.00e-15 | - | - |
rs2395185 | rs9268923 | chr6:32432835 | 1 | C | T | Colitis ulcerative | Diseases and traits | 20228798 | NA | 4.00e-15 | - | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Taking other prescription medications | Diseases and traits | UKBB | -0.00994 | 4.50e-15 | 336330 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Granulocyte percentage of myeloid white cells | Diseases and traits | 27863252 | -0.03015 | 5.68e-15 | 173480 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Monocyte percentage of white cells | Diseases and traits | 27863252 | 0.02952 | 1.71e-14 | 173480 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Pediatric Ulcerative Colitis | Diseases and traits | 18758464 | NA | 1.97e-14 | 5261 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Started insulin within one year diagnosis of diabetes | Diseases and traits | UKBB | -0.02879 | 9.34e-14 | 15397 | risk diff |
rs2395185 | rs9268923 | chr6:32432835 | 1 | C | T | Epstein Barr virus nuclear antigen 1 IgG levels | Diseases and traits | 26819262 | 0.252 | 1.00e-13 | - | unit increase |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Number of self-reported non-cancer illnesses | Diseases and traits | UKBB | -0.01548 | 1.31e-13 | 337159 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Reticulocyte count | Diseases and traits | 27863252 | -0.02872 | 1.42e-13 | 173480 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Body mass index | Diseases and traits | 28892062 | 0.02676 | 1.96e-13 | 173430 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Generalized vitiligo | Diseases and traits | 20410501 | NA | 2.11e-13 | 4021 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Self-reported diabetes | Diseases and traits | UKBB | -0.003605 | 2.37e-13 | 337159 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Classical Hodgkin lymphoma EBV negative | Diseases and traits | 22286212 | NA | 3.00e-13 | 7617 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Forced vital capacity | Diseases and traits | UKBB | 0.01487 | 4.56e-13 | 307638 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Nodular sclerosis Hodgkin lymphoma EBV negative | Diseases and traits | 22286212 | NA | 5.00e-13 | 7617 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Medication for cholesterol, blood pressure or diabetes: insulin | Diseases and traits | UKBB | -0.003137 | 5.78e-13 | 154702 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Intestinal malabsorption | Diseases and traits | UKBB | 0.0007824 | 7.54e-13 | 337199 | risk diff |
rs2395185 | rs9268853 | chr6:32429643 | 1 | T | C | Psoriasis | Diseases and traits | 19680446 | NA | 8.87e-13 | 2759 | log OR |
rs2395185 | rs9268853 | chr6:32429643 | 1 | T | C | Psoriasis | Diseases and traits | 19680446 | NA | 8.87e-13 | - | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Vitamin and mineral supplements: folic acid or folate | Diseases and traits | UKBB | -0.002533 | 2.07e-12 | 335591 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Sitting height | Diseases and traits | UKBB | 0.01373 | 2.27e-12 | 336172 | IVNT |
rs2395185 | rs9268858 | chr6:32429758 | 1 | T | C | Ulcerative colitis | Diseases and traits | 18836448 | NA | 2.58e-12 | 1944 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Self-reported ulcerative colitis | Diseases and traits | UKBB | 0.00129 | 2.95e-12 | 337159 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Insulin-dependent diabetes mellitus | Diseases and traits | UKBB | -0.0006303 | 3.74e-12 | 337199 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Overall health rating | Diseases and traits | UKBB | -0.01264 | 6.22e-12 | 336020 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Self-reported sarcoidosis | Diseases and traits | UKBB | 0.0007629 | 7.48e-12 | 337159 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Antinuclear antibody levels | Diseases and traits | 25186300 | NA | 1.00e-11 | - | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | No blood clot, bronchitis, emphysema, asthma, rhinitis, eczema or allergy diagnosed by doctor | Diseases and traits | UKBB | 0.008019 | 1.34e-11 | 336782 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Treatment with insulin | Diseases and traits | UKBB | -0.00201 | 3.03e-11 | 180203 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Forced vital capacity, best measure | Diseases and traits | UKBB | 0.01495 | 3.31e-11 | 255492 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Height | Diseases and traits | UKBB | 0.01183 | 4.70e-11 | 336474 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Reticulocyte fraction of red cells | Diseases and traits | 27863252 | -0.0255 | 5.03e-11 | 173480 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Malignant neoplasm of anus and anal canal | Diseases and traits | UKBB | -0.0002665 | 6.40e-11 | 337199 | risk diff |
rs2395185 | rs9268853 | chr6:32429643 | 1 | T | C | Lymphoma | Diseases and traits | 23349640 | -0.4447 | 2.00e-10 | - | log OR |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Seropositive rheumatoid arthritis | Diseases and traits | UKBB | -0.0003836 | 6.07e-10 | 337199 | risk diff |
rs2395185 | rs9268853 | chr6:32429643 | 1 | T | C | Multiple sclerosis | Diseases and traits | 17660530 | NA | 7.40e-10 | 5224 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Lung cancer adenocarcinoma in never smoking women | Diseases and traits | 23143601 | NA | 9.47e-10 | 10054 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Generalized vitiligo without concomitant other autoimmune disorder | Diseases and traits | 20410501 | NA | 1.18e-09 | 4021 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Treatment with sulfasalazine | Diseases and traits | UKBB | -0.0006749 | 1.30e-09 | 337159 | risk diff |
rs2395185 | rs9268853 | chr6:32429643 | 1 | T | C | Multiple sclerosis | Diseases and traits | 17660530 | NA | 1.31e-09 | 2793 | log OR |
rs2395185 | rs9268853 | chr6:32429643 | 1 | T | C | Multiple sclerosis | Diseases and traits | 17660530 | NA | 1.31e-09 | - | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Allergic disease | Diseases and traits | 29083406 | -0.0386 | 1.35e-09 | 360838 | log OR |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Self-reported polymyalgia rheumatica | Diseases and traits | UKBB | -7e-04 | 1.40e-09 | 337159 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Body mass index males | Diseases and traits | 28892062 | 0.02911 | 3.74e-09 | 90992 | IVNT |
rs2395185 | rs9268858 | chr6:32429758 | 1 | T | C | Ulcerative colitis | Diseases and traits | 20228798 | NA | 4.08e-09 | 2746 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Self-reported hypothyroidism or myxoedema | Diseases and traits | UKBB | -0.003176 | 4.20e-09 | 337159 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Medication for pain relief, constipation, heartburn: none of the above | Diseases and traits | UKBB | 0.007402 | 5.17e-09 | 333581 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Trunk fat-free mass | Diseases and traits | UKBB | 0.009303 | 5.34e-09 | 331030 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Treatment with beclometasone | Diseases and traits | UKBB | -0.001418 | 5.36e-09 | 337159 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Ulcerative colitis | Diseases and traits | UKBB | 0.001006 | 6.60e-09 | 337199 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Whole body water mass | Diseases and traits | UKBB | 0.009269 | 7.33e-09 | 331315 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Irritable bowel disorder | Diseases and traits | 19915574 | NA | 7.70e-09 | 8571 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Trunk predicted mass | Diseases and traits | UKBB | 0.009156 | 8.30e-09 | 330995 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Lung cancer in never smoking women | Diseases and traits | 23143601 | NA | 9.51e-09 | 10054 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Lung cancer | Diseases and traits | 23143601 | -0.157 | 1.00e-08 | - | log OR |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Nasal polyp | Diseases and traits | UKBB | -0.001005 | 1.22e-08 | 337199 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Eosinophil percentage of white cells | Diseases and traits | 27863252 | -0.02183 | 1.45e-08 | 173480 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Whole body fat-free mass | Diseases and traits | UKBB | 0.00907 | 1.45e-08 | 331291 | IVNT |
rs2395185 | rs9268853 | chr6:32429643 | 1 | T | C | Lymphoid malignancies | Diseases and traits | 23349640 | NA | 1.76e-08 | 4988 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Joint damage severity in rheumatoid arthritis | Diseases and traits | 23696630 | NA | 2.00e-08 | 600 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Hemoglobin concentration | Diseases and traits | 27863252 | -0.02147 | 2.17e-08 | 173480 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Classical Hodgkin lymphoma EBV positive | Diseases and traits | 22286212 | NA | 4.70e-08 | 7617 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Generalized vitiligo with concomitant other autoimmune disorder | Diseases and traits | 20410501 | NA | 5.20e-08 | 4021 | - |
rs2395185 | rs9268906 | chr6:32432181 | 1 | A | G | Oligoclonal band status positive in multiple sclerosis patients | Diseases and traits | 23472185 | NA | 5.30e-08 | 1528 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Monocyte chemoattractant protein 1 | Diseases and traits | 22291609 | NA | 8.38e-08 | 4694 | - |
rs2395185 | rs9268906 | chr6:32432181 | 1 | A | G | Oligoclonal band status in multiple sclerosis patients | Diseases and traits | 23472185 | NA | 9.20e-08 | 1528 | - |
rs2395185 | rs9268905 | chr6:32432077 | 1 | G | C | Cystic fibrosis severity | Diseases and traits | 21602797 | NA | 1.00e-07 | - | - |
rs2395185 | rs9268905 | chr6:32432077 | 1 | G | C | Cystic fibrosis | Diseases and traits | 21602797 | NA | 1.00e-07 | - | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | High light scatter reticulocyte count | Diseases and traits | 27863252 | -0.02061 | 1.07e-07 | 173480 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Multiple sclerosis | Diseases and traits | UKBB | 0.0004981 | 1.07e-07 | 337199 | risk diff |
rs2395185 | rs9268905 | chr6:32432077 | 1 | G | C | Cystic fibrosis lung disease severity | Diseases and traits | 21602797 | NA | 1.21e-07 | 2494 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Hematocrit | Diseases and traits | 27863252 | -0.02013 | 1.37e-07 | 173480 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | High density lipoprotein | Diseases and traits | 24097068 | -0.0195 | 1.55e-07 | 176745 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Vitamin and mineral supplements: none of the above | Diseases and traits | UKBB | 0.006144 | 1.61e-07 | 335591 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Treatment with paracetamol | Diseases and traits | UKBB | -0.005088 | 1.99e-07 | 337159 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Drive faster than motorway speed limit | Diseases and traits | UKBB | 0.01099 | 2.15e-07 | 306030 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Leg predicted mass right | Diseases and traits | UKBB | 0.008572 | 2.22e-07 | 331285 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Leg fat-free mass right | Diseases and traits | UKBB | 0.008581 | 2.59e-07 | 331285 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Long-standing illness, disability or infirmity | Diseases and traits | UKBB | -0.006183 | 2.60e-07 | 329663 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Basophil count | Diseases and traits | 27863252 | -0.01947 | 2.61e-07 | 173480 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Doctor diagnosed sarcoidosis | Diseases and traits | UKBB | 0.001675 | 3.60e-07 | 83529 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Treatment with salbutamol | Diseases and traits | UKBB | -0.001386 | 4.25e-07 | 337159 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Leg predicted mass left | Diseases and traits | UKBB | 0.008338 | 4.71e-07 | 331253 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Hand grip strength right | Diseases and traits | UKBB | 0.009185 | 5.08e-07 | 335842 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Forced expiratory volume in 1-second | Diseases and traits | UKBB | 0.01088 | 5.13e-07 | 307638 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Parkinsons disease | Diseases and traits | 25064009 | 0.09431 | 5.71e-07 | 108990 | log OR |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Leg fat-free mass left | Diseases and traits | UKBB | 0.008253 | 7.32e-07 | 331258 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Basal metabolic rate | Diseases and traits | UKBB | 0.00831 | 7.33e-07 | 331307 | IVNT |
rs2395185 | rs9268853 | chr6:32429643 | 1 | T | C | Asthma 18 years old | Diseases and traits | 23181788 | NA | 9.55e-07 | 3855 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Impedance of leg left | Diseases and traits | UKBB | -0.01117 | 1.30e-06 | 331296 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Arm fat-free mass right | Diseases and traits | UKBB | 0.007501 | 1.97e-06 | 331221 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Sarcoidosis | Diseases and traits | 22952805 | NA | 2.00e-06 | 1906 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Treatment with seretide 50 evohaler | Diseases and traits | UKBB | -0.001299 | 2.05e-06 | 337159 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Hypothyroidism | Diseases and traits | 22493691 | NA | 2.80e-06 | 39282 | - |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | High light scatter percentage of red cells | Diseases and traits | 27863252 | -0.01812 | 2.96e-06 | 173480 | IVNT |
rs2395185 | rs9268853 | chr6:32429643 | 1 | T | C | Ulcerative colitis | Diseases and traits | 23511034 | 0.3148 | 3.00e-06 | - | log OR |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Forced expiratory volume in 1-second, best measure | Diseases and traits | UKBB | 0.01112 | 3.03e-06 | 255492 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Illnesses of father: diabetes | Diseases and traits | UKBB | -0.003654 | 3.56e-06 | 293407 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Eye problems or disorders: diabetes related eye disease | Diseases and traits | UKBB | -0.002813 | 4.16e-06 | 108817 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Waist hip ratio adjusted for BMI | Diseases and traits | 25673412 | -0.017 | 4.80e-06 | 223003 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Medication for pain relief, constipation, heartburn: paracetamol | Diseases and traits | UKBB | -0.004777 | 5.12e-06 | 333581 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Impedance of leg right | Diseases and traits | UKBB | -0.01043 | 5.22e-06 | 331301 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Arm predicted mass right | Diseases and traits | UKBB | 0.007143 | 5.48e-06 | 331216 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Arm fat-free mass left | Diseases and traits | UKBB | 0.007306 | 5.61e-06 | 331159 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Follow-up examination after treatment for malignant neoplasm | Diseases and traits | UKBB | -0.0009892 | 6.30e-06 | 337199 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Body mass index females | Diseases and traits | 28892062 | 0.02431 | 6.41e-06 | 82438 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Self-reported thyroid radioablation therapy | Diseases and traits | UKBB | 0.0001764 | 6.50e-06 | 337159 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Waist hip ratio adjusted for smoking | Diseases and traits | 28443625 | -0.0179 | 6.55e-06 | 163851 | IVNT |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Treatment with dovobet ointment | Diseases and traits | UKBB | -0.0003879 | 6.62e-06 | 337159 | risk diff |
rs2395185 | rs9268853 | chr6:32429643 | 1 | T | C | Illnesses of siblings: diabetes | Diseases and traits | UKBB | -0.003516 | 6.70e-06 | 261075 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Mouth or teeth dental problems: mouth ulcers | Diseases and traits | UKBB | -0.003467 | 6.75e-06 | 336138 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Eosinophil percentage of granulocytes | Diseases and traits | 27863252 | -0.01736 | 7.04e-06 | 173480 | IVNT |
rs2395185 | rs9268853 | chr6:32429643 | 1 | T | C | Treatment with prednisolone | Diseases and traits | UKBB | -0.0008595 | 7.63e-06 | 337159 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Thyrotoxicosis | Diseases and traits | UKBB | 0.0003364 | 8.53e-06 | 337199 | risk diff |
rs2395185 | rs9268858 | chr6:32429758 | 1 | T | C | Treatment with becotide 50 inhaler | Diseases and traits | UKBB | -0.000881 | 8.59e-06 | 337159 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Illnesses of mother: diabetes | Diseases and traits | UKBB | -0.003363 | 9.27e-06 | 309953 | risk diff |
rs2395185 | rs373214970 | chr6:32435548 | 1 | CG | C | Neutrophil percentage of granulocytes | Diseases and traits | 27863252 | 0.01873 | 9.30e-06 | 173480 | IVNT |
rs2395185 | rs9268853 | chr6:32429643 | 1 | T | C | Self-reported type 1 diabetes | Diseases and traits | UKBB | -0.0003274 | 9.47e-06 | 337159 | risk diff |
rs2395185 | rs2395185 | chr6:32433167 | 1 | G | T | Cross disorder | Diseases and traits | 23453885 | -0.05732 | 9.70e-06 | 61220 | log OR |
rs2395185 | rs9268906 | chr6:32432181 | 1 | A | G | Red blood cell count | Diseases and traits | 27863252 | -0.01516 | 9.81e-06 | 173480 | IVNT |